Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardiomyocyte

Biochemical Journal

Volumn 438, Issue 2, 2011, Pages 379-387

  Gangopadhyay, Jaya P ^a   Ikemoto, Noriaki ^b  

^a BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Activation link; Anti CaMBD antibody; Calmodulin (CaM); Calmodulin kinase II (CaMKII); Calmodulin binding domain (CaMBD); Nuclear factor of activated T cells (NFAT); Ryanodine receptor (RyR)

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALMODULIN; CALMODULIN BINDING PROTEIN; ENDOTHELIN 1; RYANODINE RECEPTOR; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART MUSCLE CELL; HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; CALCIUM SIGNALING; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CALMODULIN; CARDIOMEGALY; CELL NUCLEUS; CELL SIZE; ENDOTHELIN-1; INTRACELLULAR SPACE; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 80051703596     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110203     Document Type: Article

References (45)

1. 2+, adenine nucleotide, and calmodulin. J. Biol. Chem. 262, 3065-3073
2. 2+ sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin. Am. J. Physiol. Cell Physiol. 279, C724-C733
3. 2+ release channel (ryanodine receptor). J. Biol. Chem. 278, 23480-23486
4. 2+ binding domain in RyR1 that interacts with the calmodulin binding site and modulates channel activity. Biophys. J. 90, 173-182
5. 2+ release induced by calmodulin binding domain peptide. Biophys. J. 90, 2015-2026
6. 2+ /agonist-induced channel activation. Biochem. J. 411, 415-423
7. Yamamoto, T., Yano, M., Xu, X., Uchinoumi, H., Tateishi, H., Mochizuki, M., Oda, T., Kobayashi, S., Ikemoto, N. and Matsuzaki, M. (2008) Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts. Circulation 117, 762-772 (Pubitemid 351640677)
8. Yano, M., Yamamoto, T., Ikemoto, N. and Matsuzaki, M. (2005) Abnormal ryanodine receptor function in heart failure. Pharmacol. Ther. 107, 377-391 (Pubitemid 41175911)
9. Chien, K. R., Grace, A. A. and Hunter, J. J. (1998) Molecular and cellular biology of cardiac hypertrophy and failure. In Molecular basis of cardiovascular disease (Chien, K. R., ed), pp. 211-250, W.B. Saunders, Philadelphia
10. Yamaguchi, N., Takahashi, N., Xu, L., Smithies, O. and Meissner, G. (2007) Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channel. J. Clin. Invest. 117, 1344-1353 (Pubitemid 46718422)
11. 2+ release in heart failure. Cardiovasc. Res. 87, 609-617
12. Xu, X., Yano, M., Uchinoumi, H., Hino, A., Suetomi, T., Ono, M., Tateishi, H., Oda, T., Okuda, S., Doi, M. et al. (2010) Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction. Biochem. Biophys. Res. Commun. 394, 660-666
13. Toth, A., Nickson, P., Quin, L. L. and Erhardt, P. (2006) Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, and E3 ubiquitin ligase. J. Biol. Chem. 281, 3679-3689 (Pubitemid 43845986)
14. Takahashi, H., Takeishi, Y., Seidler, T., Arimoto, T., Akiyama, H., Hozumi, Y., Koyama, Y., Shishido, T., Tsunoda, Y., Niizeki, T. et al. (2005) Adenovirus-mediated overexpression of diacylglycerol kinase-ζ inhibits endothelin-1-induced cardiomyocyte hypertrophy. Circulation 111, 1510-1516 (Pubitemid 40470646)
15. 2+ exchangers. J. Mol. Cell Cardiol. 41, 807-815
16. Ronkainen, J. J., Vuolteenaho, O. and Tavi, P. (2007) Calcium-calmodulin kinase II is the common factor in calcium-dependent cardiac expression and secretion of A- and B-type natriuretic peptides. Endocrinology 148, 2815-2820 (Pubitemid 46984803)
17. 2+ /calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J. Biol. Chem. 275, 15239-15245
18. Zhang, W. (2002) Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy. Cardiovasc. Res. 53, 294-303
19. Heineke, J. and Molkentin, J. (2006) Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat. Rev. Mol. Cell Biol. 7, 589-600 (Pubitemid 44325350)
20. Hamada, T., Gangopadhyay, J. P., Mandl, A., Erhardt, P. and Ikemoto, N. (2009) Defective regulation of the ryanodine receptor induces hypertrophy in cardiomyocytes. Biochem. Biophys. Res. Commun. 380, 493-497
21. 2+ /calmodulin-dependent protein kinase II during the development of hypertrophy in neonatal cardiomyocytes. Biochem. Biophys. Res. Commun. 396, 515-521
22. 2+ release in cardiomyocytes during β-adrenergic stimulation. J. Physiol. 588, 225-242
23. 2+ leak in failing hearts. Cardiovasc. Res. 536, 536-545
24. 2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ. Res. 106, 1134-1144
25. Hogan, P. G., Chen, L., Nardone, J. and Rao, A. (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205-2232 (Pubitemid 37128637)
26. 2+-calcineurin-NFAT cascade in cardiac myocytes. Cardiovasc. Res. 63, 450-457
27. Vega, R. B., Bassel-Duby, R. and Olson, E. N. (2003) Control of cardiac growth and function by calcineurin signaling. J. Biol. Chem. 278, 36981-36984 (Pubitemid 37175209)
28. Gruver, C. L, DeMayo, F., Goldstein, M. A. and Means, A. R. (1993) Targeted developmental overexpression of calmodulin induced proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology 133, 376-388 (Pubitemid 23206418)
29. Colomer, J. M. and Means, A. R. (2000) Chronic elevation of calmodulin in the ventricles of transgenic mice increases the autonomous activity of calmodulin-dependent protein kinase II, which regulates atrial natriuretic factor gene expression. Mol. Endocrinol. 14, 1125-1136 (Pubitemid 32260475)
30. Hoeflich, K. P. and Ikura, M. (2002) Calmodulin in action: diversity in target recognition and activation mechanisms. Cell 108, 739-742 (Pubitemid 34327526)
31. Crivici, A. and Ikura, M. (1995) Molecular and structural basis of target recognition by calmodulin. Annu. Rev. Biophys. Biomol. Struct. 25, 85-116
32. Persechini, A. and Stemmer, P. M. (2002) Calmodulin is a limiting factor in the cell. Trends Cardiovasc. Med. 12, 32-37 (Pubitemid 34048708)
33. Takeshima, H., Nishimura, S., Matsumoto, T., Ishida, H., Kangawa, K., Minamino, N., Matsuo, H., Ueda, M., Hanaoka, M., Hirose, T. and Numa, S. (1989) Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 339, 439-445 (Pubitemid 19145787)
34. Nakai, J., Imagawa, T., Hakamata, Y., Shigekawa, M., Takeshima, H. and Numa, S. (1990) Primary structure and functional expression from cDNA of the cardiac ryanodine receptor/calcium release channel. FEBS Lett. 271, 1-2
35. Zhu, X., Ghanta, J., Walker, J. W., Allen, P. D. and Valdivia, H. H. (2004) The calmodulin binding region of the skeletal ryanodine receptor acts as a self-modulatory domain. Cell Calcium 35, 165-177 (Pubitemid 38139675)
36. 2+ release channel (ryanodine receptor). J. Biol. Chem. 278, 23480-23486
37. 2+ release channel. Biochemistry 38, 8532-8537
38. 2+ release channel, ryanodine receptor. J. Biol. Chem. 276, 22579-22585
39. 2+ release channels and their regulation by endogenous effectors. Annu. Rev. Physiol. 56, 485-508
40. 2+ and monovalent cations and anions. J. Biol. Chem. 272, 1628-1638
41. Yamamoto, T. and Ikemoto, N. (2002) Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor. Biochem. Biophys. Res. Commun. 291, 1102-1108 (Pubitemid 34694387)
42. 2+ release in permeabilized cardiomyocytes. Cardiovasc. Res. 70, 475-485
43. Oda, T., Yano, M., Yamamoto, T., Tokuhisa, T., Okuda, S., Doi, M., Ohkusa, T., Ikeda, T., Kobayashi, S., Ikemoto, N. and Matsuzaki, M. (2005) Defective regulation of inter-domain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure. Circulation 111, 3244-3254
44. Paul-Pletzer, K., Yamamoto, T., Ikemoto, N., Jimenez, L. S., Morimoto, H., Williams, P. G., Ma, J. and Parness, J. (2005) Probing the dantrolene-binding site on the cardiac ryanodine receptor. Biochem. J. 387, 905-909 (Pubitemid 40685728)
45. Kobayashi, S., Bannister, M. L., Gangopadhyay, J. P., Hamada, T., Parness, J. and Ikemoto, N. (2005) Dantrolene stabilizes domain interactions within the ryanodine receptor. J. Biol. Chem. 280, 6580-6587 (Pubitemid 40341208)